THCT (THC Therapeutics) Purchase Of Investment : $0.00 Mil (TTM As of Apr. 2024)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics Purchase Of Investment?

THC Therapeutics's purchase of investment for the three months ended in Apr. 2024 was $0.00 Mil. It means THC Therapeutics spent $0.00 Mil on purchasing investments. THC Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Apr. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jan. 2024 ), THC Therapeutics spent the same money on purchasing investments in Apr. 2024 ($0.00 Mil).

THC Therapeutics Purchase Of Investment Historical Data

The historical data trend for THC Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Purchase Of Investment Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Purchase Of Investment

Get a 7-Day Free Trial

-0.15

THC Therapeutics Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

THC Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

THC Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX